-Stanley Nattel Researcher Activity Profile

Research Author Detailed Information 

Stanley Nattel Publication Rate By Year

Stanley Nattel has published 1 paper(s) in 1994, 2 paper(s) in 1996, 1 paper(s) in 2003, 1 paper(s) in 2005, 13 paper(s) in 2007, 11 paper(s) in 2008, for a total of 29 research publications in total.

Stanley S Nattel Author Information

LAST NAME: nattel

FIRST NAME: Stanley

INITIALS: s

AFFILIATION:

Papers

Stanley Nattel's Publication Record

1. Protein kinase C, connexin43, and ischemic preconditioning: complex interactions of potential importance for controlling arrhythmias. Year Published: 2007
2. Acute and chronic effects of cardiac resynchronization in patients developing heart failure with long-term pacemaker therapy for acquired complete atrioventricular block. Year Published: 2007
Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
3. Atrial cardiomyocyte tachycardia alters cardiac fibroblast function: A novel consideration in atrial remodeling. Year Published: 2007
4. Omega-3 polyunsaturated fatty acids prevent atrial fibrillation associated with heart failure but not atrial tachycardia remodeling. Year Published: 2007
5. Effects of resveratrol (trans-3,5,4'-trihydroxystilbene) treatment on cardiac remodeling following myocardial infarction. Year Published: 2007
6. Omega-3 polyunsaturated fatty acids prevent atrial fibrillation associated with heart failure but not atrial tachycardia remodeling. Year Published: 2007
7. Pulmonary vein reentry-Properties and size matter: Insights from a computational analysis. Year Published: 2007
Department of Biomedical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York; Department of Physics and Astronomy, Hofstra University, Hempstead, New York.
8. Protein kinase C, connexin43, and ischemic preconditioning: complex interactions of potential importance for controlling arrhythmias. Year Published: 2007
9. Effects of resveratrol (trans-3,5,4'-trihydroxystilbene) treatment on cardiac remodeling following myocardial infarction. Year Published: 2007
10. Changes in IK,ACh single-channel activity with atrial tachycardia remodelling in canine atrial cardiomyocytes. Year Published: 2008
Department of Pharmacology and Toxicology, Dresden University of Technology, Dresden, Germany.
11. Atrial tachycardia induces remodelling of muscarinic receptors and their coupled potassium currents in canine left atrial and pulmonary vein cardiomyocytes. Year Published: 2007
12. Pulmonary vein reentry--properties and size matter: insights from a computational analysis. Year Published: 2007
Department of Biomedical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York 14853, USA.
13. Pulmonary vein region ablation in experimental vagal atrial fibrillation: role of pulmonary veins versus autonomic ganglia. Year Published: 2008
Department of Medicine, Montreal Heart Institute, Montreal, Quebec, Canada.
14. Pulmonary vein region ablation in experimental vagal atrial fibrillation: role of pulmonary veins versus autonomic Ganglia. Year Published: 2008
5000 Belanger St E, Montreal, Quebec, H1T 1C8, Canada. stanley.nattel@icm-mhi.org.
15. Repolarization indices or calcium-current recovery/repolarization balance: What determines torsadogenesis? Year Published: 2008
Department of Medicine and Research Center, Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada.
16. Atrial tachycardia induces remodelling of muscarinic receptors and their coupled potassium currents in canine left atrial and pulmonary vein cardiomyocytes. Year Published: 2007
Department of Medicine, Université de Montréal and Research Center, Montreal Heart Institute, Quebec, Canada.
17. Pulmonary vein reentry--properties and size matter: insights from a computational analysis. Year Published: 2007
Department of Biomedical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York 14853, USA.
18. Case studies with the experts: management decisions in atrial fibrillation. Year Published: 2008
The Care Group, Indianapolis, Indiana 46260, USA. eprystow@thecaregroup.com
19. Pioglitazone, a peroxisome proliferator-activated receptor-gamma activator, attenuates atrial fibrosis and atrial fibrillation promotion in rabbits with congestive heart failure. Year Published: 2008
Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
20. Pulmonary vein region ablation in experimental vagal atrial fibrillation: role of pulmonary veins versus autonomic ganglia. Year Published: 2008
Department of Medicine, Montreal Heart Institute, Montreal, Quebec, Canada.
21. To the editor-response. Year Published: 2008
Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
22. Differential behaviors of atrial versus ventricular fibroblasts: a potential role for platelet-derived growth factor in atrial-ventricular remodeling differences. Year Published: 2008
5000 Belanger St E, Montreal, H1T 1C8, Quebec, Canada. stanley.nattel@icm-mhi.org.
23. Atrial fibrillation: evidence for genetically determined disease. Year Published: 2008
24. Prognostic significance of ventricular arrhythmias post-myocardial infarction. Year Published: 2003
Department of Medicine, Montreal Heart Institute, University of Montreal, Montreal, Quebec, Canada. pkhairy@cardio.tch.harvard.edu
25. Prognostic implications of transient left ventricular cavitary dilation during exercise and dipyridamole-thallium imaging. Year Published: 1994
Maisonneuve-Rosemont Hospital, Montreal Heart Institute, Quebec.
26. Restoration of sinus rhythm in patients with atrial fibrillation. Year Published: 1996
27. [Restoration of the sinus rhythm in atrial fibrillation] Year Published: 1996
28. Atrial fibrillation: basic and clinical research at the Montreal Heart Institute. Year Published: 2005
Department of Medicine and Research Centre, Montreal Heart Institute, Faculty of Medicine, University of Montreal, Quebec. d-roy@icm-mhi.com
29. Differential behaviors of atrial versus ventricular fibroblasts: a potential role for platelet-derived growth factor in atrial-ventricular remodeling differences. Year Published: 2008